Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours

American Journal of Gastroenterology

Volumn 94, Issue 2, 1999, Pages 351-357

  Netzer, Peter ^a   Gaia, Claudio ^a   Sandoz, Menga ^b   Huluk, Tomas ^b   Gut, André ^a   Halter, Fred ^a   Busier, Jiirg ^a   Inauen, Werner ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Gastrointestinal Unit   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; STOMACH PH; VOLUNTEER;

ADULT; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GASTRIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; OMEPRAZOLE; RANITIDINE; TIME FACTORS;

EID: 0033083730     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00738-2     Document Type: Article

References (49)

1. Rockall TA, Logan RF, Sawada T, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BrMed J 1995;311:222-6.
2. Ell C, Hagenmiiller F, Schmitt W, et al. Multi-centre prospective study of the current state of treatment in Germany of bleeding peptic ulcer. Dtsch Med Wschr 1995;120:3-9.
3. Oxner RB, Simmonds NJ, Gertner DJ, et al. Controlled trial of endoscopie injection treatment for bleeding from peptic ulcers with visible vessels. Lancet 1992;339:966-8.
4. Villanueva C, Balanzö J, Torras X, et al. Omeprazole versus ranitidine as adjunct therapy to endoscopie injection in actively bleeding ulcers: A prospective and randomized study. Endoscopy 1995:27:308-12.
5. Kiilerich S, Rannem R, Eisborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995;56:25-30.
6. Labenz J, Peitz U, Leusing C, et al. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: A prospective randomised controlled study. Gut 1997;40:36-41.
7. Andersen J, Ström M, Naesdal J, et al. Intravenous omeprazole: Effect of a loading dose on 24-h intragastric pH. Aliment Pharmacol Ther 1990;4:65-72.
8. Wilder-Smith CH, Halter F, Hacki W, et al. pH-Feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses. Br J Clin Pharmacol 1992;33:487-93.
9. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994:106:60-4.
10. Collins R, Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage: Implications of randomized trials. N Engl J Med 1985;313:660-6.
11. Ballesteros AM, Hogan DL, Koss MA, et al. Bolus or intravenous infusion of ranitidine: Effects on gastric pH and acid secretion. Ann Intern Med 1990;! 12:334-9.
12. Berstad A, Holm HA, Kittang E. Experience with antipeptic agents. Scand J Gastroenterol 1979;14(Suppl 55):121-3.
13. Patchett SE, Enright H, Afdhal N, et al. Clot lysis by gastric juice: An in vitro study. Gut 1989:30:1704-7.
14. Patchett SE, O'Donoghue DP. Mechanisms of intragastric clot lysis. Eur J Gastroenterol Hepatol 1991;3:633-6.
15. Patchett SE, O'Donoghue DP. Pharmacological manipulation of gastric juice: Thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Gut 1995;36:358-62.
16. Green FW, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation: A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74(Suppl l):38-43.
17. Low J, Dodds AJ, Biggs JC. Fibrinolytic activity of gastroduodenal secretions-a possible role in upper gastrointestinal haemorrhage. Thromb Res 1980;17:819-30.
18. Walt RP, Cottrell J, Mann SG, et al. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992;340:1058-62.
19. Daneshmend TK, Hawkey CI, Langman MJ, et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial. Br Med J 1992;304:143-7.
20. Chua RT, Lin HI, Wang K, et al. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: A preliminary report of a randomized controlled study. Chin Med J (Taipei) 1996;57:139-45.
21. Lanas A, Artal A, Bias JM, et al. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol 1995;21:103-6.
22. Grosso C, Rossi A, Gambitta P, et al. Non-bleeding visible vessel treatment: Perendoscopic injection therapy versus omeprazole infusion. Scand J Gastroenterol 1995:30:872-5.
23. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcérations of the upper intestinal tract: An open randomized controlled trial. Digestion 1990:45:217-25.
24. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997;336: 1054-8.
25. Cederberg C, Thompson AB, Kirdeikis P, et al. Effect of continuous intravenous infusion of omeprazole on 24 hour intragastric pH in fasting DU-patients: Comparison to repeated bolus doses of omeprazole or ranitidine. Gastroenterology 1992;102:A48.
26. Sackier JM, Halliday K, Sprott P, et al. The effects of intravenous omeprazole on 24 h gastric secretion in healthy subjects. Comparisons of continuous and intermittent infusions: A pilot study. Eur J Gastroenterol Hepatol 1991:3:679-84.
27. Teyssen S, Chari ST, Scheid J, et al. Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects. Dig Dis Sci 1995;40:247-55.
28. Merki HS, Witzel L, Walt RP, et al. Day-to-day variation of 24-hour intragastric acidity. Gastroenterology 1988;94:887-91.
29. Wilder-Smith CH, Gennoni MA, Triller J, et al. Is a fluoroscopic verification of the electrode position necessary in ambulatory intragastric pH monitoring? Digestion 1992;52:l-5.
30. Inauen W, Emde C, Weber B, et al. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: A 24 hour ambulatory combined pH and manometry study. Gut 1993:34:1025-31.
31. Merki HS, Wilder-Smith CH, Walt RP, et al. The cephalic and gastric phases of gastric secretion during H2-antagonist treatment. Gastroenterology 1991:101:599-606.
32. Merki HS, Halter F, Wilder-Smith CH. Diurnal secretory patterns and tolerance during individually titrated infusion of ranitidine. Gastroenterology 1993:105:748-54.
33. Hiirlimann S, Abbiihl B, Inauen W, et al. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994:8:193-201.
34. Wilder-Smith CH, Halter F, Ernst T, et al. Loss of acid suppression during dosina with H2-receptor antagonists. Aliment Pharmacol Ther 1990;4(Suppl lp):15-27.
35. Smith JT, Gavey CJ, Nwokolo CU, et al. Tolerance during eight days of high dose H2 blockade: Placebo controlled study of 24 hour acidity and gastrin. Gut 1989:30:1387-91.
36. Hettmansperger TP. Statistical inference based on ranks. New York: Wiley, 1984.
37. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984:40:1079-87.
38. Holm S. A simple sequentially rejective multiple test procedure. Scand Statist 1979;6:65-70.
39. Hirschowitz BI, Keeling D, Lewin M, et al. Pharmacological aspects of acid secretion. Dig Dis Sci 1995;40:3S-23S.
40. Sachs G. Therapeutic control of acid secretion: Pharmacology of the parietal cell. Gastroenterology 1990;6:859-66.
41. Scott DR, Besancon M, Sachs G, et al. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo. Dig Dis Sci 1994;39:2118-26.
42. Smit MJ, Leurs R, Alewijnse AE, et al. Inverse agonism of histamine H2 antagonists accounts for upregulation of spontaneously active histamine H2 receptors. Proc Natl Acad Sci USA 1996;93:6802-7.
43. Fryklund J, Gedda K, Wallmark B. Specific labelling of gastric H+, K+-ATPase by omeprazole. Biochem Pharmacol 1988;37:2543-9.
44. De Graef J, Woussen-Colle M-C. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs. Gastroenterology 1986;91:333-7.
45. Isenberg JI, Grossman MI, Maxwell V. Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer. J Clin Invest 1975;55:330-7.
46. Halter F, Bangerter U, Haecki WH, et al. Sensitivity of the parietal cell to pentagastrin in health and duodenal ulcer disease: A reappraisal. Scand J Gastroenterol 1982;17:539-44.
47. Hurlimann S, Dur S, Schwab P, et al. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Am J Gastroenterol 1998;93:1277-85.
48. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Scand J Gastroenterol 1997;32:320-7.
49. Hasseigren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Scand J Gastroenterol 1997:32:328-33.